Biotech
> Kevin Fitzpatrick has been named the chief innovation officer of the American College of Cardiology. Release
> The National Institute for Pharmaceutical Technology and Education named Ajaz Hussain its new executive director. Release
> Mast Therapeutics' ($MSTX) Patrick Keran will be stepping down from his position as chief operating officer in February. Release
> Paragon Bioservices brought on Mike Billard as its vice president of project management, George Buchman as its vice president of preclinical services and process development and Maryanne Foy as its vice president of human resources and corporate administration. Release
> Bobby Sandage joined Euclises as the company's CEO. Release
> Ferring Pharmaceuticals hired Dr. Pascal Danglas as its executive vice president and chief medical officer and Dr. Per Falk as its executive vice president and chief scientific officer. Release
> Idera Pharmaceuticals ($IDRA) appointed R. Clayton Fletcher as its senior vice president of business development and strategic planning and Jim Baker as its executive director of market development. Release
> Applied Genetic Technologies ($AGTC) has appointed Stephen Potter as chief business officer. Release
> Nabriva Therapeutics appoints Charles Rowland to its supervisory board and names Steven Gelone chief development officer and a member of the management team. Release
> Elena Kasimova joins Cleveland BioLabs' ($CBLI) board of directors. Release
> Epizyme ($EPZM) appoints Robert Copeland as president of research. Release
> Acurian appoints Roger Smith, formerly senior vice president of Acurian operations, as senior vice president and general manager. Release
> Certara promotes Amin Rostami to senior vice president of R&D and chief scientific officer. Release
> Crown Bioscience appoints Laurie Heilmann as the new senior vice president of global strategy and marketing business development. Release
> Mary Thistle, formerly of Cubist ($CBST), joins Dimension Therapeutics, a 2014 Fierce 15 company, as chief business officer. Release
> Essen BioScience appoints Jim Ryder as global head of sales. Release
> Karolinska Development ($KDEV) CEO Bruno Lucidi is leaving the company and Deputy CEO Terje Kalland is acting CEO until a new CEO is appointed. Release | Story
Pharma
> Inovio ($INO) appoints Dr. Mark Gelder as vice president of clinical development. Release
> Columbia Labs ($CBRX) is looking for a new board member to follow the upcoming retirement of Chairman Stephen Kasnet. Release
> Cerulean Pharma ($CERU) names Tiffany Crowell as vice president of clinical operations. Release
> Gilead Sciences ($GILD) promoted Dr. Andrew Cheng to executive vice president of HIV therapeutics and development operations and Taiyin Yang to executive vice president of pharmaceutical development and manufacturing. Release
Drug Delivery
> PhytoTech appoints Daphna Heffetz as CEO of its Israeli subsidiary. Release
|